JPO's dismissal of CRISPR patent invalidation appealed to Japan IP court
South Korean biotech company ToolGen is appealing the Japanese patent office’s dismissal of its invalidation petition related to a CRISPR patent held by the University of California, Nobel laureate Emmanuelle Charpentier...To view the full article, register now.
Already a subscriber? Click here to view full article